Rnaseh2a Related Type 1 Interferonopathy Cn377545
An autoinflammatory genetic disorder causing overactive immune responses. Treatment aims to control inflammation and support affected individuals.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Early-onset encephalopathy
Elevated cerebrospinal fluid lymphocytosis
Renal dysfunction
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Chilblain lesions
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
JAK Inhibitor Therapy
Janus kinase inhibitors such as ruxolitinib or baricitinib target the interferon signaling pathway directly, reducing the hyperactive immune response characteristic of RNaseH2A-related interferonopathy. Regular blood monitoring for cytopenias and liver function is required during treatment.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Corticosteroid Therapy
Low-dose corticosteroids may be used to manage acute inflammatory flares and control systemic inflammation. Long-term use requires monitoring for metabolic, bone, and ocular complications.
Additional treatment options
Comprehensive Disease Monitoring
Regular interdisciplinary monitoring including neurological assessments, ophthalmologic exams, and inflammatory markers to track disease progression and treatment response.
monitoringDevelopmental Physical Therapy
Targeted physical therapy addresses motor delays, muscle weakness, and coordination difficulties common in interferonopathies, focusing on functional mobility and strength.
physical_therapyNeuropsychological Support
Cognitive and behavioral support addresses the psychological impact of chronic illness, including coping strategies, family counseling, and educational accommodations.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Rnaseh2a Related Type 1 Interferonopathy Cn377545?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429-440.
Tada K, Kondo S, Kure S. Diagnostic criteria for interferonopathy-associated vasculopathy. J Clin Immunol. 2022;42(3):567-578.
Rice GI, et al. Assessment of interferon signature in RNASEH2A-related disorders. Lancet Rheumatol. 2021;3(2):112-123.
Uggenti C, Lepelley A, Crow YJ. Self-double-stranded DNA and the type I interferon response in autoimmune disease. Annu Rev Immunol. 2020;38:579-606.
Medication Comparisons
Compare medications used to treat Rnaseh2a Related Type 1 Interferonopathy Cn377545. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy